©The Author(s) 2019. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Endosc. Jun 16, 2019; 11(6): 424-426
Published online Jun 16, 2019. doi: 10.4253/wjge.v11.i6.424
Published online Jun 16, 2019. doi: 10.4253/wjge.v11.i6.424
Has the time been reached for pseudopolyps to be re-enrolled in endoscopic inflammatory bowel disease scores?
Dimitrios S Politis, Konstantinos H Katsanos, Dimitrios K Christodoulou, Department of Gastroenterology, University Hospital of Ioannina, Faculty of Medicine, School of Health Sciences, University of Ioannina, Ioannina 45110, Greece
Konstantinos Papamichael, Center for Inflammatory Bowel Diseases, Division of Gastroenterology, Beth-Israel Deaconess Medical Center, Harvard Medical School, Boston, MA 02215, United States
Maria Saridi, General Hospital of Corinth, Department of Social and Educational Policy, University of Peloponnese, Corinth 20100, Greece
Eleni Albani, Department of Nursing, TEI of Western Greece, Patra 26334, Greece
Author contributions: All authors contributed to the conception, literature review, drafting and revising of the manuscript, and provided approval of the final form.
Conflict-of-interest statement: All authors declare no conflicts of interest.
Corresponding author: Dimitrios S Politis, FEBGH, MD, PhD, Doctor, Department of Gastroenterology, University Hospital of Ioannina, Faculty of Medicine, School of Health Sciences, University of Ioannina, Leoforos Stavrou Niarchou, Ioannina 45110, Greece. politisdimitrios1@gmail.com
Telephone: +30-26510-99867 Fax: +30-26510-07016
Received: May 5, 2019
Peer-review started: May 8, 2019
First decision: May 31, 2019
Revised: June 5, 2019
Accepted: June 10, 2019
Article in press: June 10, 2019
Published online: June 16, 2019
Processing time: 42 Days and 12.2 Hours
Peer-review started: May 8, 2019
First decision: May 31, 2019
Revised: June 5, 2019
Accepted: June 10, 2019
Article in press: June 10, 2019
Published online: June 16, 2019
Processing time: 42 Days and 12.2 Hours
Core Tip
Core tip: Interest in pseudopolyps and their relationship for monitoring inflammatory bowel disease activity has been refreshed by two recent studies that showed the presence of pseudopolyps to be linked with escalation of treatment, including the increased need for use of biological agents. The next logical step in their management is including their evaluation and possible integration, after proper validation, in inflammatory bowel disease scores, as separate markers for prediction of a more severe clinical course.